In this task, you are given a summary for US Congressional and California state bill, your task is to generate a Title for this bill. The preferred titles are under forty words and mention the purpose of the bill.

[EX Q]: Security Clearance Enhancement Act of 2014 - Amends the Intelligence Reform and Terrorism Prevention Act of 2004 to expand the responsibilities of the executive agency selected to conduct security clearance investigations of U.S. government employees and contractors who require access to classified information. Requires such agency to provide for: (1) the collection of data from government, commercial data, consumer reporting agency, and social media sources, as well as data relevant to the granting, denial, or revocation of access to classified information; (2) periodic reinvestigations to review the accuracy and comprehensiveness of information relating to such access; and (3) a process to notify an agency if a verification or periodic reinvestigation has revealed information pertinent to revocation of access. Requires personnel security investigations of an individual to include information collected from:  criminal or civil legal proceedings;   financial information sources, including bankruptcy proceedings, property liens, mortgages, high-value assets obtained from unknown sources, and bank accounts;   credit reports or wealth indicators;  associations with an individual or group that may suggest ill intent, vulnerability to blackmail, compulsive behavior, allegiance to another country, or change in ideology;  public sources, including news articles or reports;  social media websites or forums; and   terrorist or criminal watch lists maintained by an agency, state or local government, or international organization, including the Office of Foreign Assets Control of the Department of the Treasury, the Federal Bureau of Investigation (FBI), and the International Criminal Police Organization.  Requires data collected during reinvestigations to be included in the security clearance database established by the Office of Personnel Management (OPM). Increases the frequency of periodic investigations conducted for the purpose of updating a previously completed background investigation to two times (currently, once) every: (1) 5 years in the case of a top secret clearance or access to a highly sensitive program, (2) 10 years in the case of a secret clearance, or (3) 15 years in the case of a confidential clearance. Reestablishes an annual report to Congress regarding security clearances. Requires such reports to assess the effectiveness of OPM's security clearance database. Prohibits this Act from being construed to require increased consideration of information relating to an individual's minor financial or mental health issues.
[EX A]: Security Clearance Enhancement Act of 2014

[EX Q]: Amends the Federal Food, Drug, and Cosmetic Act to require license applications for new drugs and biological products to assess such drug's or product's safety and effectiveness for relevant pediatric subpopulations, including dosage.Permits extrapolation from adult studies where the course of the disease and the effects of the drug are sufficiently similar in all populations.Permits deferral of such assessments if adult studies are completed earlier and the applicant submits a plan for or a description of planned or ongoing pediatric studies.Permits full waiver of such assessments if: (1) studies are highly impractical or impossible; (2) the evidence strongly suggests that the drug or product would be ineffective or unsafe in all pediatric age groups; (3) there is no meaningful therapeutic advantage or benefit in the pediatric population; or (4) the drug or product is not likely to be used in a substantial number of pediatric patients.Permits partial waivers at the request of an applicant for a specific pediatric subpopulation if any of the full waiver grounds apply to that subpopulation or reasonable attempts for a pediatric formulation for that subpopulation have failed.Requires labels to provide indication in cases in which a waiver has been granted due to evidence a product would be unsafe or ineffective in pediatric populations.Authorizes the Secretary of Health and Human Services to specify a date for submission of pediatric assessments if: (1) the drug or biological product would represent a meaningful therapeutic benefit for pediatric patients for one or more claimed indications and the absence of adequate labeling could pose significant risks to pediatric patients; or (2) it is used for a number of pediatric patients for the labeled indications and the absence of adequate labeling could pose significant risks to pediatric patients. Sets forth criteria for full waiver and partial waivers of such requirement. Requires labels to provide indication in cases in which a waiver has been granted due to evidence a product would be unsafe or ineffective in pediatric populations.Requires the Secretary to issue a written request for related pediatric studies under the Public Health Service Act before requiring an assessment for a drug.States that drugs or products with delayed assessments may be deemed misbranded and subject to seizure and injunctive proceedings, though not penalties.
[EX A]: To amend the Federal Food, Drug, and Cosmetic Act to require labeling containing information applicable to pediatric patients.

[EX Q]: Colon Cancer Screen for Life Act of 2002 - Expresses the sense of the Congress with respect to the use of and reimbursement for colorectal cancer screening tests covered under the Medicare program under title XVIII of the Social Security Act (SSA).Amends SSA title XVIII to: (1) increase reimbursement for colorectal cancer screening and diagnostic tests; (2) cover an outpatient office visit or consultation for the purpose of beneficiary education before a colorectal cancer screening test consisting of a screening colonoscopy or in conjunction with the beneficiary's decision to obtain such a screening, regardless of whether such screening is medically indicated with respect to the beneficiary; and (3) waive the deductible for colorectal cancer screening tests.
[EX A]:
To amend title XVIII of the Social Security Act to improve patient access to, and utilization of, the colorectal cancer screening benefit under the Medicare Program.